Summarized by Masters of Longevity from Frontiers - Health.
Wearable sensor technologies for early, subclinical detection of chemotherapy-related nerve injury; what the article reviews and why it matters to clinicians and researchers.
Key Takeaways
- Quantitative sensory testing shows vibration, thermal, and sudomotor deficits appear one to two chemotherapy cycles before symptoms.
- Wearable modalities reviewed include IMU gait analysis, plantar pressure insoles, electrochemical skin conductance, and wearable vibration sensors.
- Existing evidence is largely cross-sectional and the paper proposes a phased prospective validation framework before clinical deployment.
